Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $3.04 million as of July 10, 2026. Its market cap has increased by 69,898.74% in one year.

Market Cap

3.04M

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 3.04M, a decrease of -83.95%. That is a compound annual growth rate of -7.80%.

Market Cap History

Date	Market Cap	% Change
Jul 7, 2026	3.04M	-
Dec 31, 2025	3.04M	600.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
REMSleep Holdings	4.58M
QHSLab	4.06M
Biotricity	3.63M
Linike Medical Group	3.55M
Ludwig Enterprises	3.31M
Sonendo	2.87M
Holdco Nuvo Group D.G	2.30M
CYduct Diagnostics	2.20M

Market Cap Rankings